Home
HelpTest Code TSIM Targeted Gabapentinoid and Stimulant Mass Spectrometry Screen, Random, Urine (Non-Orderable)
Specimen Required
Only orderable as part of profile. For more information see:
CSMHP / Controlled Substance Monitoring Hybrid Plus Drug Profile, 19 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
PMHPU / Pain Management Hybrid Profile, 22 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
TGSU / Targeted Gabapentinoid and Stimulant High-Resolution Accurate Mass Spectrometry Screen, Random, Urine
Supplies: Sarstedt Aliquot Tube 5 mL (T914)
Collection Container/Tube: Plastic urine container
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Collect a random urine specimen.
2. No preservative
Useful For
Only orderable as part of profile. For more information see:
CSMHP / Controlled Substance Monitoring Hybrid Plus Drug Profile, 19 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
PMHPU / Pain Management Hybrid Profile, 22 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
TGSU / Targeted Gabapentinoid and Stimulant High-Resolution Accurate Mass Spectrometry Screen, Random, Urine
Aiding in the determination of compliance or identify illicit stimulant drug use
This test is not intended for use in employment-related testing.
Special Instructions
Reporting Name
Gabapentinoid/Stim MS Screen, USpecimen Type
UrineSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Urine | Refrigerated (preferred) | 14 days |
| Frozen | 28 days |
Reject Due To
| Gross hemolysis | OK |
| Gross icterus | Reject |
Reference Values
Only orderable as part of profile. For more information see:
CSMHP / Controlled Substance Monitoring Hybrid Plus Drug Profile, 19 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
PMHPU / Pain Management Hybrid Profile, 22 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine
TGSU / Targeted Gabapentinoid and Stimulant High-Resolution Accurate Mass Spectrometry Screen, Random, Urine
Not detected (Positive results are reported with qualitative "Present" results)
Cutoff concentrations:
Methamphetamine: 100 ng/mL
Amphetamine: 100 ng/mL
3,4-Methylenedioxymethamphetamine (MDMA): 100 ng/mL
3,4-Methylenedioxy-N-ethylamphetamine (MDEA): 100 ng/mL
3,4-Methylenedioxyamphetamine (MDA): 100 ng/mL
Ephedrine: 100 ng/mL
Pseudoephedrine: 100 ng/mL
Phentermine: 100 ng/mL
Phencyclidine (PCP): 20 ng/mL
Methylphenidate: 20 ng/mL
Ritalinic acid: 100 ng/mL
Gabapentin: 500 ng/mL
Pregabalin: 500 ng/mL
Method Description
The urine sample is diluted with internal standard and clinical laboratory reagent water and then analyzed by liquid chromatography tandem mass spectrometry using a high-resolution accurate mass orbitrap detector.(Unpublished Mayo method)
Day(s) Performed
Monday through Sunday
Report Available
3 to 4 daysSpecimen Retention Time
14 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
G0480
80326 (if appropriate for select payers)
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| TSIM | Gabapentinoid/Stim MS Screen, U | 99107-5 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 624198 | Methamphetamine | 19554-5 |
| 624199 | Amphetamine | 19343-3 |
| 624200 | 3,4-methylenedioxymethamphetamine (MDMA) | 19568-5 |
| 624201 | 3,4-methylenedioxy-N-ethylamphetamine (MDEA) | 59844-1 |
| 624202 | 3,4-methylenedioxyamphetamine (MDA) | 19565-1 |
| 624203 | Ephedrine | 99108-3 |
| 624204 | Pseudoephedrine | 99109-1 |
| 624205 | Phentermine | 19674-1 |
| 624206 | Phencyclidine (PCP) | 19659-2 |
| 624207 | Methylphenidate | 19577-6 |
| 624208 | Ritalinic acid | 99110-9 |
| 624209 | Gabapentin | 68439-9 |
| 624210 | Pregabalin | 105953-4 |
| 624211 | Stimulant Interpretation | 54247-2 |